These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 783196

  • 21. [Immunity of the skin--infection and percutaneous immunization of rabbits with E. coli ATCC 13676].
    Hammerschmidt W, Hellmann E.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):252-67. PubMed ID: 3892981
    [Abstract] [Full Text] [Related]

  • 22. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E, Naumann G, Broschewitz U.
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [Abstract] [Full Text] [Related]

  • 23. Significance of antibody-coated bacteria in urinary sediment in experimental pyelonephritis.
    Smith JW, Jones SR, Kaijser B.
    J Infect Dis; 1977 Apr; 135(4):577-81. PubMed ID: 323377
    [Abstract] [Full Text] [Related]

  • 24. Complex formation between Escherichia coli lipopolysaccharide O antigen and capsular K antigen as detected by immunoelectrophoresis.
    Orskov F, Orskov I.
    APMIS; 1991 Jul; 99(7):615-9. PubMed ID: 1712600
    [Abstract] [Full Text] [Related]

  • 25. [Significance of the number of pathogens in the development of antibody titer and experimental pyelonephritis].
    Loew H, Küster K, Ritzerfeld W.
    Int J Clin Pharmacol; 1972 Aug; 6(3):276-84. PubMed ID: 4567538
    [No Abstract] [Full Text] [Related]

  • 26. The secretory antibody response in milk and bile against fimbriae and LPS in rats monocolonized or immunized in the Peyer's patches with Escherichia coli.
    Dahlgren UI, Wold AE, Hanson LA, Midtvedt T.
    Immunology; 1990 Oct; 71(2):295-300. PubMed ID: 1977693
    [Abstract] [Full Text] [Related]

  • 27. [Immunobiological study of colibacterial pyelonephritis].
    Podoplelov II, Samoĭlenko AS, Iudina II, Bakanova DIa, Burtsev VI.
    Urol Nefrol (Mosk); 1974 Oct; (2):3-5. PubMed ID: 4141146
    [No Abstract] [Full Text] [Related]

  • 28. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN, Massironi SG, Arslanian C, Palmeira P, Carneiro-Sampaio MM, Nagao AT.
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [Abstract] [Full Text] [Related]

  • 29. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG, Graham DY, Evans DJ.
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [Abstract] [Full Text] [Related]

  • 30. Local immune response to upper urinary tract infections in children.
    Kantele A, Palkola N, Arvilommi H, Honkinen O, Jahnukainen T, Mertsola J, Kantele JM.
    Clin Vaccine Immunol; 2008 Mar; 15(3):412-7. PubMed ID: 18184820
    [Abstract] [Full Text] [Related]

  • 31. O, K, H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis.
    Orskov I, Orskov F, Birch-Andersen A, Kanamori M, Svanborg-Edén C.
    Scand J Infect Dis Suppl; 1982 Mar; 33():18-25. PubMed ID: 6127800
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [E. coli serum antibodies in pyelonephritis: their detection with monovalent O-antigens of known blood groups, with polyvalent antigens, isolated from patients' urine].
    Túri S, Petheö G, Boda K, Temesvári P, Czirók E.
    Acta Paediatr Acad Sci Hung; 1979 Mar; 20(2-3):199-209. PubMed ID: 397713
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The immune response to urinary tract infections in childhood. I. Serological diagnosis of primary symptomatic infection in girls by indirect hemagglutination.
    Jodal U.
    Acta Paediatr Scand; 1975 Jan; 64(1):96-104. PubMed ID: 1090109
    [Abstract] [Full Text] [Related]

  • 36. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC.
    Vaccine; 2005 Mar 31; 23(19):2430-8. PubMed ID: 15752829
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
    Falkenhagen U, Handschuck I, Nimmich W, Zingler G, Naumann G.
    Z Urol Nephrol; 1984 Nov 31; 77(11):629-38. PubMed ID: 6395557
    [Abstract] [Full Text] [Related]

  • 39. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ, Weinstein R, Rene P.
    Scand J Infect Dis Suppl; 1982 Nov 31; 33():79-82. PubMed ID: 6127805
    [Abstract] [Full Text] [Related]

  • 40. The antibody response of children with pyelonephritis to different antigens of E. coli.
    Holmgren J, Eggertsen G, Hansson LA, Jodal U, Lincoln K, Winberg J.
    Acta Pathol Microbiol Scand; 1968 Nov 31; 72(3):457. PubMed ID: 4967987
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.